Neuropathic pain affects an estimated 7 to 10% of the general population, making it one of the most common chronic pain conditions
Neuropathy Treatment in La Crosse, WI: Relief for Nerve Pain That Won't Respond to Conventional Treatment
Neuropathic pain is notoriously difficult to treat with standard medications. IV ketamine therapy targets the central pain pathways that drive neuropathy, offering meaningful relief for patients who have cycled through gabapentinoids, antidepressants, and opioids without adequate results.
Neuropathic Pain Doesn't Respond Like Normal Pain. It Needs a Different Kind of Treatment.
Neuropathic pain, pain caused by damage or dysfunction of the nervous system itself, affects an estimated 7 to 10% of the general population. It’s characterized by burning, shooting, stabbing, or electric sensations that don’t follow the normal rules of pain: it can occur without any ongoing tissue damage, persist long after an injury has healed, and respond poorly to the medications that work for other types of pain.
Standard neuropathy treatments, including gabapentin, pregabalin, duloxetine, and tricyclic antidepressants, provide adequate relief for some patients but leave many others still struggling with significant daily pain. Opioids are often prescribed but carry serious risks and tend to become less effective over time. For patients who haven’t found adequate relief through these approaches, ketamine therapy offers something genuinely different.
IV ketamine blocks NMDA receptors in the central nervous system, directly modulating the pain signaling pathways that drive neuropathic pain. It doesn’t mask symptoms. It intervenes at the neurological mechanism maintaining the pain. At Relevate Ketafusion, we offer IV ketamine infusions specifically for neuropathic pain, delivered under continuous medical supervision right here in La Crosse.


Understanding Neuropathy: When the Nervous System Becomes the Source of Pain
Neuropathic pain arises when the peripheral or central nervous system is damaged, compressed, or malfunctioning in a way that causes it to generate pain signals inappropriately. Unlike nociceptive pain, which is the normal protective response to tissue damage, neuropathic pain is generated by the nervous system itself rather than by ongoing injury. The sensation it produces is often described as burning, electric, shooting, or stabbing, and it can be accompanied by hypersensitivity to touch, temperature changes, and spontaneous pain with no clear trigger.
A key neurological process in neuropathic pain is central sensitization, the same mechanism that drives CRPS. When pain signals persist, the central nervous system amplifies its response over time, lowering the pain threshold and making the nervous system increasingly reactive. NMDA receptors play a central role in this sensitization process, which is why ketamine, one of the most potent NMDA receptor antagonists available, has such direct relevance for neuropathic pain.
Hear from Those Who've Found Hope

Call us
(608) 518-3915Address
2309 State Road La Crosse, WI 54601
Working hours
Mon-Thu: 7:30 am - 7:30 pm
Fri-Sat: 7:30 am - 12:30 pm
Book Your Consultation
Fill out the form below, and we’ll contact you shortly.
Types of Neuropathy and Nerve Pain We Treat
Neuropathic pain has many causes, but the central sensitization mechanism that sustains it is common across presentations. Ketamine therapy has shown meaningful benefit across a range of neuropathic pain conditions.
Diabetic Neuropathy
Diabetic peripheral neuropathy is one of the most common forms of neuropathy, affecting up to 50% of people with diabetes over time. The burning, tingling, and shooting pain typically begins in the feet and works upward, and standard medications provide inadequate relief for a significant portion of patients. Ketamine's ability to modulate central pain processing offers a meaningful alternative for diabetic neuropathy patients who haven't responded to gabapentin, duloxetine, or other first-line treatments.
Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Chemotherapy agents can cause lasting damage to peripheral nerves, producing painful tingling, numbness, and burning that persists long after treatment ends. CIPN is undertreated and significantly affects quality of life for cancer survivors. Ketamine therapy's central pain modulation mechanism makes it relevant for CIPN, addressing the amplified pain signaling that standard analgesics struggle to reach.
Postherpetic Neuralgia
Postherpetic neuralgia is the persistent nerve pain that follows a shingles infection, sometimes lasting years after the rash has cleared. The burning, stabbing, and hypersensitivity it produces can be severe and debilitating, and conventional treatments provide only partial relief for many patients. Ketamine's NMDA receptor blocking action addresses the central sensitization component of postherpetic neuralgia directly.
Idiopathic Peripheral Neuropathy
In many cases of peripheral neuropathy, no clear cause can be identified despite thorough evaluation. This idiopathic presentation is frustrating for both patients and clinicians. Regardless of the underlying cause, the central sensitization that sustains the pain responds to ketamine therapy's mechanism, making it a relevant option even when the origin of the neuropathy is unclear.
Small Fiber Neuropathy
Small fiber neuropathy involves damage to the small nerve fibers that transmit pain and temperature signals, often producing intense burning pain that standard nerve conduction studies may not detect. It can be associated with autoimmune conditions, diabetes, or occur without a clear cause. Ketamine therapy's central mechanism of action means it can address the pain amplification process regardless of whether large or small nerve fibers are involved.
Neuropathy with Co-Occurring Depression or Anxiety
Depression and anxiety are extremely common in people living with chronic neuropathic pain, each making the other worse. Emotional distress amplifies pain perception through shared neurological pathways, and the demoralization of living with daily, uncontrolled pain creates a cycle that's difficult to break. Ketamine therapy's simultaneous effect on pain and mood makes it uniquely suited for this combination.
Your Neuropathy Treatment Journey at Relevate Ketafusion
From your first conversation to your last session, we're with you at every step.
01
Initial Consultation
Your journey starts with a virtual consultation. We'll talk through your neuropathy history, the character and distribution of your pain, the treatments you've tried, and your goals. Dr. Schumaker will review your case carefully to determine whether IV ketamine is appropriate and what protocol makes the most clinical sense for your presentation. We'll set realistic expectations about what treatment can and can't achieve.
02
Personalized Treatment Plan
03
Treatment Sessions
Every session takes place in a private, calm treatment room with continuous medical supervision. Our team monitors your vitals, your pain response, and your comfort in real time throughout every infusion, adjusting as needed. Plan to have someone drive you home afterward and allow adequate rest time following each session.
04
Monitoring and Maintenance
We track your pain response carefully across your initial series and adjust the plan based on your results. The duration of pain relief following ketamine treatment varies by patient and by the specific neuropathic condition being treated. Maintenance infusion schedules are built around your individual response, aiming for the longest possible period of meaningful relief with the least frequent treatment necessary.
Our Neuropathy Treatment: IV Ketamine Infusion
For neuropathic pain, IV ketamine infusion is our primary treatment modality. The IV route provides precise dosing, immediate bioavailability, and real-time adjustability that other delivery methods can't match for pain conditions.
IV Ketamine Therapy for Neuropathic Pain
Neuropathy infusion protocols are calibrated differently from standard mental health infusion protocols. Sessions may run longer, and dosing is determined by Dr. Schumaker based on your specific pain presentation, history, and response. Most neuropathy patients complete an initial series of infusions over 2 to 4 weeks, with maintenance infusions scheduled based on how long pain relief is sustained. IV ketamine is a self-pay treatment and not covered by insurance. Pricing for extended pain infusions differs from standard session pricing.
Learn More
Spravato (Esketamine) Therapy
Spravato is FDA-approved for treatment-resistant depression and MDD with suicidal ideation. For neuropathy patients who also experience significant depression or anxiety alongside their pain, Spravato may be considered as a complementary option for the mood components of their condition. Your provider will discuss whether this makes sense during your consultation. Spravato is covered by most major insurance plans.
Learn More
The Science Behind Ketamine for Neuropathic Pain
Neuropathic pain persists because of central sensitization: the nervous system has become abnormally reactive, amplifying pain signals far beyond what the original nerve damage warrants. NMDA receptors are central to this sensitization process. When pain signals repeatedly activate NMDA receptors, they lower the pain threshold, increase signal amplitude, and create a self-sustaining cycle of pain that doesn’t require ongoing nerve damage to continue.
Ketamine is one of the most potent NMDA receptor antagonists available in clinical medicine. By blocking NMDA receptors, it interrupts the central sensitization process, essentially resetting the pain system’s amplification settings. This is a direct intervention at the neurological mechanism sustaining neuropathic pain, not symptom management. The effect can persist well beyond ketamine’s direct pharmacological action, suggesting that blocking NMDA receptors gives the sensitized nervous system an opportunity to recalibrate.

Why Choose Relevate Ketafusion for Neuropathy Treatment
01
A Different Mechanism When Standard Medications Have Failed
Gabapentin, pregabalin, duloxetine, and tricyclic antidepressants all target the peripheral or synaptic aspects of neuropathic pain. Ketamine targets the central sensitization process itself. For patients who haven’t responded adequately to first-line medications, this different mechanism of action isn’t just an alternative. It’s the next logical clinical step.
02
A Medical Director Who Understands Pain Neuroscience at the Molecular Level
Dr. Howard Schumaker’s dual board certifications in Family and Emergency Medicine, combined with his chemical engineering background, mean he understands ketamine’s mechanism of action in central pain modulation in exceptional depth. He personally oversees every neuropathy treatment protocol at Relevate, bringing both clinical expertise and molecular-level understanding to your care.
03
The Only IV Ketamine Clinic in the Coulee Region
Relevate Ketafusion is the only provider in the La Crosse area offering IV ketamine infusions. The nearest alternative is over two hours away. For someone managing daily neuropathic pain, that distance is a real barrier to accessing care that could meaningfully change their quality of life.
04
Pain and Mood Treated Together
Depression and anxiety in neuropathy patients don’t just co-occur with pain. They actively amplify it through shared neural pathways. Ketamine therapy addresses both simultaneously, which no first-line neuropathy medication can claim. For patients managing both chronic pain and significant mood symptoms, that dual effect is clinically significant.
05
Continuous Medical Supervision at Every Session
Every session happens under direct medical supervision with continuous vital sign monitoring. Our team adjusts your infusion in real time based on your response, ensuring both safety and optimal therapeutic effect at every visit.
06
Transparent, Honest About What to Expect
We won’t promise that ketamine eliminates neuropathic pain entirely. What we will promise is an honest evaluation of your case, a treatment protocol built around your specific presentation, and careful tracking of your response. Some patients achieve dramatic long-term relief. Others achieve meaningful reduction that improves daily functioning. Our job is to give you the best possible outcome with full transparency about what that looks like for you.
Blogs
Insights & Resources
Explore articles that empower your path to wellness.

March 25, 2026
Hope Beyond Traditional Antidepressants: Exploring New Paths to Healing

March 18, 2026
The Role of Integration After Ketamine Sessions

March 11, 2026
Understanding Dissociation: Why Some People Experience It and How It Is Managed During Treatment